PMC:7228307 / 60295-60638 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T456","span":{"begin":115,"end":123},"obj":"Body_part"}],"attributes":[{"id":"A456","pred":"fma_id","subj":"T456","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"Future directions in the development and use of therapeutic antibodies should increasingly mimic normal protective antibody responses, which are polyclonal and elicited in the context of innate receptor engagement which includes the FcR as well as other powerfully responsive systems including the Toll‐like receptors and complement receptors."}

{"project":"LitCovid-sample-Enju","denotations":[{"id":"T455","span":{"begin":0,"end":6},"obj":"JJ"},{"id":"T456","span":{"begin":7,"end":17},"obj":"NNS"},{"id":"T457","span":{"begin":18,"end":20},"obj":"IN"},{"id":"T458","span":{"begin":21,"end":24},"obj":"DT"},{"id":"T459","span":{"begin":25,"end":36},"obj":"NN"},{"id":"T460","span":{"begin":37,"end":40},"obj":"CC"},{"id":"T461","span":{"begin":41,"end":44},"obj":"NN"},{"id":"T462","span":{"begin":45,"end":47},"obj":"IN"},{"id":"T463","span":{"begin":48,"end":59},"obj":"JJ"},{"id":"T464","span":{"begin":60,"end":70},"obj":"NNS"},{"id":"T465","span":{"begin":71,"end":77},"obj":"MD"},{"id":"T466","span":{"begin":78,"end":90},"obj":"RB"},{"id":"T467","span":{"begin":91,"end":96},"obj":"VB"},{"id":"T468","span":{"begin":97,"end":103},"obj":"JJ"},{"id":"T469","span":{"begin":104,"end":114},"obj":"JJ"},{"id":"T470","span":{"begin":115,"end":123},"obj":"NN"},{"id":"T471","span":{"begin":124,"end":133},"obj":"NNS"},{"id":"T472","span":{"begin":133,"end":134},"obj":"-COMMA-"},{"id":"T473","span":{"begin":135,"end":140},"obj":"WDT"},{"id":"T474","span":{"begin":141,"end":144},"obj":"VBP"},{"id":"T475","span":{"begin":145,"end":155},"obj":"JJ"},{"id":"T476","span":{"begin":156,"end":159},"obj":"CC"},{"id":"T477","span":{"begin":160,"end":168},"obj":"VBN"},{"id":"T478","span":{"begin":169,"end":171},"obj":"IN"},{"id":"T479","span":{"begin":172,"end":175},"obj":"DT"},{"id":"T480","span":{"begin":176,"end":183},"obj":"NN"},{"id":"T481","span":{"begin":184,"end":186},"obj":"IN"},{"id":"T482","span":{"begin":187,"end":193},"obj":"JJ"},{"id":"T483","span":{"begin":194,"end":202},"obj":"NN"},{"id":"T484","span":{"begin":203,"end":213},"obj":"NN"},{"id":"T485","span":{"begin":214,"end":219},"obj":"WDT"},{"id":"T486","span":{"begin":220,"end":228},"obj":"VBZ"},{"id":"T487","span":{"begin":229,"end":232},"obj":"DT"},{"id":"T488","span":{"begin":233,"end":236},"obj":"NNS"},{"id":"T489","span":{"begin":237,"end":239},"obj":"RB"},{"id":"T490","span":{"begin":240,"end":244},"obj":"RB"},{"id":"T491","span":{"begin":245,"end":247},"obj":"IN"},{"id":"T492","span":{"begin":248,"end":253},"obj":"JJ"},{"id":"T493","span":{"begin":254,"end":264},"obj":"RB"},{"id":"T494","span":{"begin":265,"end":275},"obj":"JJ"},{"id":"T495","span":{"begin":276,"end":283},"obj":"NNS"},{"id":"T496","span":{"begin":284,"end":293},"obj":"VBG"},{"id":"T497","span":{"begin":294,"end":297},"obj":"DT"},{"id":"T498","span":{"begin":298,"end":307},"obj":"JJ"},{"id":"T499","span":{"begin":308,"end":317},"obj":"NNS"},{"id":"T500","span":{"begin":318,"end":321},"obj":"CC"},{"id":"T501","span":{"begin":322,"end":332},"obj":"NN"},{"id":"T502","span":{"begin":333,"end":342},"obj":"NNS"}],"relations":[{"id":"R467","pred":"arg1Of","subj":"T456","obj":"T455"},{"id":"R468","pred":"arg1Of","subj":"T456","obj":"T457"},{"id":"R469","pred":"arg2Of","subj":"T460","obj":"T457"},{"id":"R470","pred":"arg1Of","subj":"T460","obj":"T458"},{"id":"R471","pred":"arg1Of","subj":"T459","obj":"T460"},{"id":"R472","pred":"arg2Of","subj":"T461","obj":"T460"},{"id":"R473","pred":"arg1Of","subj":"T460","obj":"T462"},{"id":"R474","pred":"arg2Of","subj":"T464","obj":"T462"},{"id":"R475","pred":"arg1Of","subj":"T464","obj":"T463"},{"id":"R476","pred":"arg1Of","subj":"T456","obj":"T465"},{"id":"R477","pred":"arg2Of","subj":"T467","obj":"T465"},{"id":"R478","pred":"arg1Of","subj":"T467","obj":"T466"},{"id":"R479","pred":"arg1Of","subj":"T456","obj":"T467"},{"id":"R480","pred":"arg2Of","subj":"T471","obj":"T467"},{"id":"R481","pred":"arg1Of","subj":"T471","obj":"T468"},{"id":"R482","pred":"arg1Of","subj":"T471","obj":"T469"},{"id":"R483","pred":"arg1Of","subj":"T471","obj":"T470"},{"id":"R484","pred":"arg1Of","subj":"T471","obj":"T472"},{"id":"R485","pred":"arg1Of","subj":"T471","obj":"T473"},{"id":"R486","pred":"arg1Of","subj":"T471","obj":"T474"},{"id":"R487","pred":"arg2Of","subj":"T476","obj":"T474"},{"id":"R488","pred":"arg1Of","subj":"T471","obj":"T475"},{"id":"R489","pred":"arg1Of","subj":"T475","obj":"T476"},{"id":"R490","pred":"arg2Of","subj":"T477","obj":"T476"},{"id":"R491","pred":"arg2Of","subj":"T471","obj":"T477"},{"id":"R492","pred":"arg1Of","subj":"T477","obj":"T478"},{"id":"R493","pred":"arg2Of","subj":"T480","obj":"T478"},{"id":"R494","pred":"arg1Of","subj":"T480","obj":"T479"},{"id":"R495","pred":"arg1Of","subj":"T480","obj":"T481"},{"id":"R496","pred":"arg2Of","subj":"T484","obj":"T481"},{"id":"R497","pred":"arg1Of","subj":"T484","obj":"T482"},{"id":"R498","pred":"arg1Of","subj":"T484","obj":"T483"},{"id":"R499","pred":"arg1Of","subj":"T480","obj":"T485"},{"id":"R500","pred":"arg1Of","subj":"T480","obj":"T486"},{"id":"R501","pred":"arg2Of","subj":"T491","obj":"T486"},{"id":"R502","pred":"arg1Of","subj":"T491","obj":"T487"},{"id":"R503","pred":"arg1Of","subj":"T491","obj":"T489"},{"id":"R504","pred":"arg1Of","subj":"T491","obj":"T490"},{"id":"R505","pred":"arg1Of","subj":"T488","obj":"T491"},{"id":"R506","pred":"arg2Of","subj":"T495","obj":"T491"},{"id":"R507","pred":"arg1Of","subj":"T495","obj":"T492"},{"id":"R508","pred":"arg1Of","subj":"T495","obj":"T493"},{"id":"R509","pred":"arg1Of","subj":"T495","obj":"T494"},{"id":"R510","pred":"arg1Of","subj":"T495","obj":"T496"},{"id":"R511","pred":"arg2Of","subj":"T500","obj":"T496"},{"id":"R512","pred":"arg1Of","subj":"T500","obj":"T497"},{"id":"R513","pred":"arg1Of","subj":"T499","obj":"T498"},{"id":"R514","pred":"arg1Of","subj":"T499","obj":"T500"},{"id":"R515","pred":"arg2Of","subj":"T502","obj":"T500"},{"id":"R516","pred":"arg1Of","subj":"T502","obj":"T501"}],"text":"Future directions in the development and use of therapeutic antibodies should increasingly mimic normal protective antibody responses, which are polyclonal and elicited in the context of innate receptor engagement which includes the FcR as well as other powerfully responsive systems including the Toll‐like receptors and complement receptors."}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T334","span":{"begin":0,"end":343},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Future directions in the development and use of therapeutic antibodies should increasingly mimic normal protective antibody responses, which are polyclonal and elicited in the context of innate receptor engagement which includes the FcR as well as other powerfully responsive systems including the Toll‐like receptors and complement receptors."}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T455","span":{"begin":115,"end":123},"obj":"Body_part"}],"attributes":[{"id":"A455","pred":"fma_id","subj":"T455","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"Future directions in the development and use of therapeutic antibodies should increasingly mimic normal protective antibody responses, which are polyclonal and elicited in the context of innate receptor engagement which includes the FcR as well as other powerfully responsive systems including the Toll‐like receptors and complement receptors."}

{"project":"LitCovid-sentences","denotations":[{"id":"T334","span":{"begin":0,"end":343},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Future directions in the development and use of therapeutic antibodies should increasingly mimic normal protective antibody responses, which are polyclonal and elicited in the context of innate receptor engagement which includes the FcR as well as other powerfully responsive systems including the Toll‐like receptors and complement receptors."}